loadpatents
name:-0.053922891616821
name:-0.031744003295898
name:-0.0046079158782959
Chand; Pooran Patent Filings

Chand; Pooran

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chand; Pooran.The latest application filed is for "processes for preparing ag-10, its intermediates, and salts thereof".

Company Profile
4.34.49
  • Chand; Pooran - Birmingham AL
  • Chand; Pooran - San Francisco CA
  • Chand; Pooran - Durham NC
  • Chand; Pooran - Brimingham AL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antiviral Treatments
App 20220040137 - BABU; Yarlagadda S. ;   et al.
2022-02-10
Processes For Preparing Ag-10, Its Intermediates, And Salts Thereof
App 20220041558 - Chand; Pooran ;   et al.
2022-02-10
Processes for preparing AG-10, its intermediates, and salts thereof
Grant 11,078,162 - Chand , et al. August 3, 2
2021-08-03
Processes For Preparing Ag-10, Its Intermediates, And Salts Thereof
App 20200247756 - Kind Code
2020-08-06
Process for preparing AG-10, its intermediates, and salts thereof
Grant 10,513,497 - Chand , et al. Dec
2019-12-24
Antiviral Treatments
App 20190358187 - BABU; Yarlagadda S. ;   et al.
2019-11-28
Antiviral treatments
Grant 10,391,075 - Babu , et al. A
2019-08-27
Processes For Preparing AG-10, Its Intermediates, and Salts Thereof
App 20180237396 - Chand; Pooran ;   et al.
2018-08-23
PFKFB3 inhibit and methods of use as an anti-cancer therapeutic
Grant 10,010,542 - Tapolsky , et al. July 3, 2
2018-07-03
Antiviral Treatments
App 20180015063 - BABU; Yarlagadda S ;   et al.
2018-01-18
Method For Treating Macrophage Migration Inhibitory Factor (mif)-implicated Diseases And Conditions With Iodo Pyrimidine Derivatives
App 20180009764 - Mitchell; Robert A. ;   et al.
2018-01-11
Antiviral treatments
Grant 9,770,427 - Babu , et al. September 26, 2
2017-09-26
Pfkfb3 Inhibit And Methods Of Use As An Anti-cancer Therapeutic
App 20170258783 - Tapolsky; Gilles H. ;   et al.
2017-09-14
PFKFB3 inhibitor and methods of use as an anti-cancer therapeutic
Grant 9,649,305 - Tapolsky , et al. May 16, 2
2017-05-16
Small molecule inhibitors of PFKFB3 and glycolytic flux and their methods of use as anti-cancer therapeutics
Grant 9,403,769 - Chand , et al. August 2, 2
2016-08-02
Small molecule choline kinase inhibitors, screening assays, and methods for treatment of neoplastic disorders
Grant 9,381,172 - Clem , et al. July 5, 2
2016-07-05
Method For Treating Macrophage Migration Inhibitory Factor (mif)-implicated Diseases And Conditions With Iodo Pyrimidine Derivatives
App 20150368207 - Mitchell; Robert A. ;   et al.
2015-12-24
Iodo pyrimidine derivatives useful for the treatment of macrophage migration inhibitory factor (MIF)-implicated diseases and conditions
Grant 9,162,987 - Mitchell , et al. October 20, 2
2015-10-20
Pfkfb3 Inhibitor And Methods Of Use As An Anti-cancer Therapeutic
App 20150064175 - Tapolsky; Gilles H. ;   et al.
2015-03-05
Antiviral Treatments
App 20140309301 - Babu; Yarlagadda S. ;   et al.
2014-10-16
Antiviral treatments
Grant 8,778,997 - Babu , et al. July 15, 2
2014-07-15
Family of PFKFB3 inhibitors with anti-neoplastic activities
Grant 8,557,823 - Tapolsky , et al. October 15, 2
2013-10-15
Antiviral nucleoside analogs
Grant 8,440,813 - Babu , et al. May 14, 2
2013-05-14
Novel Iodo Pyrimidine Derivatives Useful For The Treatment Of Macrophage Migration Inhibitory Factor (mif)-implicated Diseases And Conditions
App 20130079361 - Mitchell; Robert A. ;   et al.
2013-03-28
Hepatitis C Therapies
App 20130078218 - Babu; Yarlagadda S. ;   et al.
2013-03-28
Small Molecule Inhibitors of PFKFB3 and Glycolytic Flux and Their Methods of Use as Anti-Cancer Therapeutics
App 20130059879 - Chand; Pooran ;   et al.
2013-03-07
Small Molecule Choline Kinase Inhibitors, Screening Assays, and Methods for Treatment of Neoplastic Disorders
App 20130012557 - Clem; Brian ;   et al.
2013-01-10
Methods for the preparation of 9-deazapurine derivatives
Grant 8,344,132 - Chand , et al. January 1, 2
2013-01-01
Therapeutic Furopyrimidines And Thienopyrimidines
App 20120213735 - Babu; Yarlagadda S. ;   et al.
2012-08-23
Tetrahydrofuro [3,4-D] dioxolane compounds for use in the treatment of viral infections and cancer
Grant 8,242,085 - Babu , et al. August 14, 2
2012-08-14
Family Of Pfkfb3 Inhibitors With Anti-neoplastic Activities
App 20120177749 - Tapolsky; Gilles ;   et al.
2012-07-12
Antiviral Therapeutic Agents
App 20120142617 - Babu; Yarlagadda S. ;   et al.
2012-06-07
Hepatitis C therapies
Grant 8,163,703 - Babu , et al. April 24, 2
2012-04-24
Therapeutic furopyrimidines and thienopyrimidines
Grant 8,133,870 - Babu , et al. March 13, 2
2012-03-13
Antiviral Treatments
App 20120059057 - Babu; Yarlagadda Sudhakara ;   et al.
2012-03-08
Small-Molecule Choline Kinase Inhibitors as Anti-Cancer Therapeutics
App 20110257211 - Chand; Pooran ;   et al.
2011-10-20
Small Molecule Choline Kinase Inhibitors, Screening Assays, and Methods for Safe and Effective Treatment of Neoplastic Disorders
App 20110212994 - CLEM; BRIAN ;   et al.
2011-09-01
Antiviral therapeutic agents
Grant 7,994,139 - Babu , et al. August 9, 2
2011-08-09
Piperidine Derivatives As Jak3 Inhibitors
App 20110165183 - Babu; Yarlagadda S. ;   et al.
2011-07-07
Synthetic Intermediates And Processes
App 20110144321 - Chand; Pooran ;   et al.
2011-06-16
Intramuscular Antiviral Treatments
App 20110015264 - Babu; Yarlagadda S. ;   et al.
2011-01-20
Tetrahydrofuro [3,4-d] Dioxolane Compounds For Use In The Treatment Of Viral Infections And Cancer
App 20110002886 - Babu; Yarlagadda S. ;   et al.
2011-01-06
Hepatitis C Therapies
App 20100143300 - Babu; Yarlagadda S. ;   et al.
2010-06-10
Methods For The Preparation Of 9-deazapurine Derivatives
App 20100093991 - Chand; Pooran ;   et al.
2010-04-15
Antiviral Nucleoside Analogs
App 20100015094 - Babu; Yarlagadda S. ;   et al.
2010-01-21
Process For Preparing Nucleoside Analogs
App 20090247750 - Kotian; Pravin L. ;   et al.
2009-10-01
Antiviral Therapeutic Agents
App 20090227524 - Babu; Yarlagadda S. ;   et al.
2009-09-10
AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
Grant 7,560,434 - Babu , et al. July 14, 2
2009-07-14
Hepatitis C therapies
Grant 7,514,410 - Babu , et al. April 7, 2
2009-04-07
Therapeutic Furopyrimidines and Thienopyrimidines
App 20080300200 - Babu; Yarlagadda S. ;   et al.
2008-12-04
Therapeutic furopyrimidines and thienopyrimidines
Grant 7,429,571 - Chand , et al. September 30, 2
2008-09-30
Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
Grant 7,388,002 - Babu , et al. June 17, 2
2008-06-17
Intramuscular antiviral treatments
App 20070244193 - Babu; Yarlagadda S. ;   et al.
2007-10-18
Antiviral treatments
App 20070203241 - Babu; Yarlagadda Sudhakara ;   et al.
2007-08-30
Process for the preparation of substituted pyrrolidine derivatives and intermediates
Grant 7,230,119 - Chand , et al. June 12, 2
2007-06-12
AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
App 20070099942 - Babu; Yarlagadda S. ;   et al.
2007-05-03
Hepatitis C therapies
App 20060234963 - Babu; Yarlagadda S. ;   et al.
2006-10-19
Therapeutic furopyrimidines and thienopyrimidines
App 20060165655 - Babu; Yarlagadda S. ;   et al.
2006-07-27
Process for the preparation of substituted pyrrolidine derivatives and intermediates
App 20060128789 - Chand; Pooran ;   et al.
2006-06-15
Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
App 20060122391 - Babu; Yarlagadda S. ;   et al.
2006-06-08
Compounds useful for inhibiting paramyxovirus neuraminidase
Grant 7,045,535 - Chand , et al. May 16, 2
2006-05-16
Biaryl compounds as serine protease inhibitors
Grant 6,936,719 - Babu , et al. August 30, 2
2005-08-30
Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
App 20050080053 - Babu, Yarlagadda S. ;   et al.
2005-04-14
Nucleosides preparation thereof and use as inhibitors of rna viral polymerases
App 20050033051 - Babu, Yarlagadda S ;   et al.
2005-02-10
Cyclopentene nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
App 20040242599 - Chand, Pooran ;   et al.
2004-12-02
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
App 20040229839 - Babu, Yarlagadda S. ;   et al.
2004-11-18
Biaryl compounds as serine protease inhibitors
App 20040162281 - Babu, Yarlagadda S. ;   et al.
2004-08-19
Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
App 20040138170 - Montgomery, John A. ;   et al.
2004-07-15
Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates
Grant 6,762,316 - Chand , et al. July 13, 2
2004-07-13
Biaryl compounds as serine protease inhibitors
Grant 6,699,994 - Babu , et al. March 2, 2
2004-03-02
Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
App 20040014722 - Babu, Yarlagadda S. ;   et al.
2004-01-22
Compounds useful for inhibiting paramyxovirus neuraminidase
App 20030187063 - Chand, Pooran ;   et al.
2003-10-02
Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
Grant 6,562,861 - Babu , et al. May 13, 2
2003-05-13
Cyclopentane and cyclopentene compounds and use for detecting influenza virus
Grant 6,503,745 - Chand , et al. January 7, 2
2003-01-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed